Cowen Trims Clover Health Investments (NASDAQ:CLOV) Target Price to $1.75

Clover Health Investments (NASDAQ:CLOVGet Rating) had its price objective cut by Cowen to $1.75 in a research note published on Wednesday, Stock Target Advisor reports.

Other research analysts have also issued reports about the stock. SVB Leerink lowered their price objective on shares of Clover Health Investments from $3.00 to $1.50 and set a market perform rating on the stock in a research note on Tuesday, November 8th. Citigroup decreased their target price on shares of Clover Health Investments from $3.50 to $1.80 and set a neutral rating on the stock in a research report on Wednesday. Canaccord Genuity Group decreased their target price on shares of Clover Health Investments from $7.00 to $4.00 in a research report on Tuesday, November 8th. Finally, Credit Suisse Group cut their price target on shares of Clover Health Investments from $3.50 to $3.00 and set an underperform rating for the company in a report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of Hold and a consensus price target of $3.01.

Clover Health Investments Trading Up 3.9 %

CLOV opened at $1.33 on Wednesday. The firm’s fifty day simple moving average is $1.70 and its 200 day simple moving average is $2.30. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.05. Clover Health Investments has a 12 month low of $1.22 and a 12 month high of $5.87. The stock has a market capitalization of $635.66 million, a P/E ratio of -1.36 and a beta of 1.95.

Hedge Funds Weigh In On Clover Health Investments

Large investors have recently modified their holdings of the business. Nicholas Hoffman & Company LLC. bought a new position in shares of Clover Health Investments during the first quarter valued at $36,000. Lazard Asset Management LLC bought a new position in shares of Clover Health Investments during the first quarter valued at $35,000. Atria Wealth Solutions Inc. acquired a new stake in shares of Clover Health Investments during the first quarter worth $36,000. WMS Partners LLC acquired a new stake in shares of Clover Health Investments during the first quarter worth $43,000. Finally, Forum Financial Management LP acquired a new stake in shares of Clover Health Investments during the first quarter worth $43,000. Institutional investors own 25.75% of the company’s stock.

About Clover Health Investments

(Get Rating)

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses.

Featured Stories

Analyst Recommendations for Clover Health Investments (NASDAQ:CLOV)

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.